Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLGW) Liabilities and Shareholders Equity (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $1.7 million as the latest value for Q3 2017.

  • Quarterly Liabilities and Shareholders Equity rose 116.3% to $1.7 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2017, down 47.92% year-over-year, with the annual reading at $701140.0 for FY2016, N/A changed from the prior year.
  • Liabilities and Shareholders Equity for Q3 2017 was $1.7 million at Bone Biologics, up from $868389.0 in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $4.3 million in Q1 2016, with the low at $701140.0 in Q4 2016.